Etta Biotech X-Porator F1 Flow-Through Electroporation System
| Brand | Etta Biotech |
|---|---|
| Origin | Jiangsu, China |
| Manufacturer Type | Authorized Distributor |
| Country of Origin | China |
| Model | X-Porator F1 |
| Price Range | USD 110,000 – 138,000 (FOB) |
| High-Voltage Range | 30–600 VDC |
| Low-Voltage Range | 30–600 VDC |
| Output Waveform | Square Wave |
| Cell Processing Volume | 3–250 mL per run |
| Cell Capacity | 1.5×10⁷–1.0×10¹⁰ viable eukaryotic cells per run |
| Recommended Cell Density | 1×10⁸ cells/mL |
| Compatible Vessels | Corning 15 mL, 50 mL, and 250 mL conical centrifuge tubes |
| Flow Rate | 1–50 mL/min |
| Input Voltage | 210–240 VAC |
| Operating System | Embedded Linux |
| Dimensions (W×D×H) | 623 × 452 × 325 mm |
| Weight | 28 kg |
Overview
The Etta Biotech X-Porator F1 is a high-capacity, flow-through electroporation system engineered for scalable, reproducible transfection of suspension-phase eukaryotic cells under controlled, GMP-aligned conditions. Unlike conventional cuvette-based or microfluidic electroporators, the X-Porator F1 employs a proprietary continuous-flow electrode architecture that generates a spatially uniform electric field across large-volume cell suspensions—enabling efficient membrane permeabilization without thermal runaway or localized arcing. Its square-wave DC output (30–600 VDC), precisely regulated in real time, ensures consistent pulse delivery independent of sample conductivity drift during processing. Designed for translational research and early-stage biomanufacturing, the system bridges the gap between discovery-scale transfection and process-ready scalability—supporting single-run processing of up to 250 mL at densities up to 1×10⁸ cells/mL, corresponding to ≥1×10¹⁰ total viable cells.
Key Features
- Continuous-flow electroporation platform with validated throughput of 3–250 mL per run—among the highest volumetric capacities available globally for non-viral transient transfection.
- Patented flow-through electrode design delivering uniform electric field distribution at low applied voltages, minimizing Joule heating and preserving membrane integrity.
- GMP-compliant disposable processing sets: sterilized by gamma irradiation, manufactured in ISO Class 7 cleanrooms, and certified for endotoxin levels ≤0.25 EU/mL.
- Etta-optimized electroporation buffer formulated to stabilize cytosolic pH, suppress ROS generation, and enhance plasmid uptake—validated for >75% transfection efficiency and >80% post-electroporation viability in CHO, HEK293, and primary T-cell lines.
- Embedded Linux control system with deterministic real-time pulse regulation, audit-trail logging, and user-accessible parameter scripting (voltage, pulse width, number of pulses, inter-pulse interval).
- Modular hardware interface supporting integration with upstream cell harvest systems and downstream collection vessels—compatible with standard Corning 15 mL, 50 mL, and 250 mL conical centrifuge tubes.
Sample Compatibility & Compliance
The X-Porator F1 is validated for suspension-adapted eukaryotic cell lines including CHO-S, HEK293F, Expi293F, and primary human T lymphocytes. It does not support adherent cells, bacteria, or yeast without prior adaptation to suspension culture. All consumables comply with ISO 10993-5 (cytotoxicity) and ISO 11137 (radiation sterilization). The system’s firmware and software architecture are designed to meet ALCOA+ data integrity principles; full electronic records—including operator ID, timestamped pulse parameters, flow rate, and temperature monitoring logs—are retained onboard for ≥12 months and exportable in CSV/CSV-TSV format. While not FDA-cleared as a medical device, the platform supports development workflows aligned with ICH Q5A, USP , and EMA Guideline on Quality of Biotechnological Products.
Software & Data Management
The X-Porator F1 runs on a dedicated embedded Linux OS with a touchscreen GUI optimized for laboratory environments. The control interface permits full parameter definition (voltage, pulse duration, number of pulses, repetition frequency, flow rate ramping profile) and includes preloaded protocols for common applications (e.g., CAR-T mRNA electroporation, antibody expression in CHO). All session data—including raw voltage/current waveforms sampled at ≥100 kHz, real-time flow sensor output, and thermal feedback from integrated NTC sensors—is timestamped and stored locally with SHA-256 hash integrity verification. Audit trails are immutable and include user login/logout events, parameter changes, and error codes. Exported datasets conform to MIAME-compliant metadata standards and are compatible with LIMS integration via RESTful API (HTTPS/TLS 1.2+).
Applications
- Accelerated therapeutic protein and monoclonal antibody production: Enables rapid screening of expression constructs and clones at volumes sufficient for functional assay validation—reducing timeline from weeks to days compared to lipofection or viral methods.
- CAR-T and CAR-NK cell engineering: Supports GMP-adjacent transient transfection of clinical-grade T cells using mRNA or plasmid DNA, eliminating reliance on lentiviral vectors during R&D and Phase I manufacturing.
- Cell line development (CLD): Facilitates high-efficiency transfection of pool generation and single-cell cloning workflows, particularly where antibiotic selection or FACS sorting follows electroporation.
- Vaccine vector optimization: Used in preclinical evaluation of DNA vaccine candidates requiring large-scale antigen-expressing cell batches for immunogenicity testing.
- Biosafety-level 2 (BSL-2) compliant operations: Fully enclosed fluid path and sealed electrode chamber minimize aerosol risk during processing of infectious or oncogenic cell lines.
FAQ
What cell types are validated for use with the X-Porator F1?
Suspension-adapted mammalian cell lines (e.g., CHO-S, HEK293F, Jurkat) and primary human T cells. Adherent cells require enzymatic detachment and resuspension in optimized buffer prior to processing.
Is the system compliant with 21 CFR Part 11 requirements?
The X-Porator F1 supports core Part 11 elements—including electronic signatures, audit trails, and secure data export—but requires site-specific validation documentation and procedural controls to achieve full compliance in regulated environments.
Can I use third-party electroporation buffers?
Etta Biotech strongly recommends its proprietary buffer due to formulation-specific synergy with the electrode geometry and pulse profile; third-party buffers may yield inconsistent viability or transfection efficiency and void consumable warranty coverage.
What maintenance is required for long-term operation?
No routine calibration is needed. Electrode modules are disposable and replaced per run. Annual firmware updates and optional preventive maintenance (PM) service packages—including flow sensor recalibration and thermal sensor verification—are available through authorized Etta service partners.
Does the system support automated integration with liquid handlers or bioreactors?
Yes—via RS-232, USB-C (CDC ACM), and Ethernet interfaces. OEM integration kits with protocol-triggered I/O signals (TTL/relays) and OPC UA support are available under NDA for industrial customers.

